Axogen (AXGN) vs Butterfly Network (BFLY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Butterfly Network (BFLY) has outperformed Axogen (AXGN) over the past year, gaining 230.8% versus a gain of 113.3%. Over five years, AXGN leads with a +164.6% price change compared with -22.3% for BFLY. Butterfly Network is the larger company by market cap ($2.20 billion vs $2.11 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AXGN | BFLY |
|---|---|---|
| Share price | $36.04 | $8.27 |
| Market cap | $2.11B | $2.20B |
| 1-day change | -0.74% | -4.94% |
| YTD return | +10.11% | +117.63% |
| 1-year return | +113.25% | +230.80% |
| 5-year return | +164.61% | -22.27% |
| Forward P/E | 52.38 | — |
| EPS (TTM) | $-0.67 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $52.91 | $10.21 |
| 52-week low | $15.27 | $1.90 |
| Distance from 52-week high | -31.88% | -19.00% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +49.33% | +37.85% |
| Average volume | 1.22M | 6.24M |
| Shares outstanding | 58.67M | 244.86M |
| Employees | 622 | 220 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Electronics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BFLY has outperformed AXGN by 117.5 percentage points over the past year.
About Axogen
AXGN stock →Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 622 employees
About Butterfly Network
BFLY stock →Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
Health Care · Medical Electronics · 220 employees
AXGN vs BFLY FAQ
Which is bigger, Axogen or Butterfly Network?
Butterfly Network (BFLY) is larger, with a market capitalization of $2.20B compared with $2.11B for Axogen (AXGN).
Which stock has performed better over the past year, AXGN or BFLY?
BFLY returned +230.80% over the past 12 months, compared with +113.25% for AXGN (price return, excluding dividends). Past performance does not predict future results.
Are Axogen and Butterfly Network in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Axogen and Medical Electronics for Butterfly Network.